Skip to main content
VCbacked
Log inGet Started

AgeX Therapeutics

Alameda, United States

AgeX is a biotechnology company that develops novel therapeutics for age-related degenerative diseases.

$36.0M raised
Jul 2023
Post-IPO Equity
BiotechnologyHealth CareTherapeutics

Top Investors

JuvenescenceLineage Cell TherapeuticsKIZOO Technology CapitalJim MellonIBS Capital

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about AgeX Therapeutics

How much funding has AgeX Therapeutics raised?
AgeX Therapeutics has raised $36.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in July 2023.
Who are AgeX Therapeutics's investors?
AgeX Therapeutics's investors include Juvenescence, Lineage Cell Therapeutics, KIZOO Technology Capital, Jim Mellon, IBS Capital.
Where is AgeX Therapeutics headquartered?
AgeX Therapeutics is headquartered in Alameda, United States.
What does AgeX Therapeutics do?
AgeX is a biotechnology company that develops novel therapeutics for age-related degenerative diseases.
What stage is AgeX Therapeutics at?
AgeX Therapeutics is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"AgeX Therapeutics — Funding & Investors." VCBacked, July 21, 2023, https://www.vcbacked.co/company/agex-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2023). AgeX Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/agex-therapeutics
Wikipedia (cite web)
{{cite web |title=AgeX Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/agex-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Renaissance BioScience
Vancouver$599K
Allterum Therapeutics
Houston$1.0M
Rapport Therapeutics
Boston$250.0M
AlpalifeBio
Woburn$9.8M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K